Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Prescribing new drugs: qualitative study of influences on consultants and general practitioners

Open access
Jones, Miren I, Greenfield, Sheila M, Bradley, Colin P·2001·BMJ

Abstract

Objective: To explore consultants' and general practitioners' perceptions of the factors that influence their decisions to introduce new drugs into their clinical practice. Design: Qualitative study using semistructured interviews. Monitoring of hospital and general practice prescribing data for eight new drugs. Setting: Teaching hospital and nearby general hospital plus general practices in Birmingham. Participants: 38 consultants and 56 general practitioners who regularly referred to the teaching hospital. Main outcome measures: Reasons for prescribing a new drug; sources of information used for new drugs; extent of contact between consultants and general practitioners; and amount of study drugs used in hospitals and by general practitioners. Results: Consultants usually prescribed new drugs only in their specialty, used few new drugs, and used scientific evidence to inform their decisions. General practitioners generally prescribed more new drugs and for a wider range of conditions, but their approach varied considerably both between general practitioners and between drugs for the same general practitioner. Drug company representatives were an important source of information for general practitioners. Prescribing data were consistent with statements made by respondents. Conclusions: The factors influencing the introduction of new drugs, particularly in primary care, are more multiple and complex than suggested by early theories of drug innovation. Early experience of using a new drug seems to strongly influence future use. What is already known on this topic: UK studies show that use of new drugs by general practitioners is influenced by consultants, the nature of the drug, and perceived risk What this study adds: Consultants generally introduced fewer drugs than general practitioners, usually within their specialty Decisions were said to be based mainly on the evidence from the scientific literature and meetings General practitioners prescribed more new drugs and the basis of decisions was more varied Doctors' interpretations of using a new drug were not consistent

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.323.7309.378

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 21

  1. Ferner, 1996, Newly licensed drugs., BMJ, 313, 1157, 10.1136/bmj.313.7066.1157 · doi:10.1136/bmj.313.7066.1157
  2. 10.1016/0277-9536(90)90042-Q · DOI
  3. Griffin, 1993, The economic implications of therapeutic conservatism., J R Coll Physicians Lond, 27, 121
  4. Williamson, 1975, How general practitioners assess risks in using new drugs., J R Coll Gen Pract, 25, 383
  5. 10.1177/014107688207500510 · doi:10.1177/014107688207500510
  6. 10.1177/014107688007301208 · doi:10.1177/014107688007301208
  7. 10.1177/014107688808100407 · doi:10.1177/014107688808100407
  8. Taylor, 1991, Changes in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice., Br J Gen Pract, 41, 244
  9. Bryman A Burgess RG eds.Analysing qualitative data. London: Routledge, 1994.
  10. 10.1093/fampra/18.3.333 · doi:10.1093/fampra/18.3.333
  11. Jones, 1999, A survey of the advertising of nine new drugs in the general practice literature., J Clin Pharm Ther, 24, 451, 10.1046/j.1365-2710.1999.00255.x · doi:10.1046/j.1365-2710.1999.00255.x
  12. Avorn, 1982, Scientific versus commercial sources of influence on the prescribing behaviour of physicians., Am J Med, 73, 4, 10.1016/0002-9343(82)90911-1 · DOI · Paper page
  13. Allery, 1997, Why general practitioners and consultants change their clinical practice: a critical incident study., BMJ, 314, 870, 10.1136/bmj.314.7084.870 · DOI · Paper page
  14. 10.1136/bmj.312.7036.949 · DOI · Paper page
  15. Tomlin, 1999, General practitioners' perceptions of effective healthcare., BMJ, 318, 1532, 10.1136/bmj.318.7197.1532 · DOI
  16. Barrie, 1997, Questioning behaviour in general practice: a pragmatic study., BMJ, 315, 1512, 10.1136/bmj.315.7121.1512 · DOI
  17. Berkwits, 1998, From practice to research: the case for criticism in an age of evidence., Soc Sci Med, 47, 1539, 10.1016/S0277-9536(98)00232-9 · DOI
  18. 10.1093/fampra/16.4.407 · DOI
  19. Walshe K Sheldon TA .Dealing with clinical risk: implications of the rise of evidence based health care. Public Money Manag 1998; Oct-Dec:15–20. · doi:10.1111/1467-9302.00136
  20. 10.1016/S0277-9536(98)00250-0 · DOI
  21. Jones, 2000, Prescribing new drugs: a survey of hospital consultants in the West Midlands., Int J Pharm Pract, 8, 285, 10.1111/j.2042-7174.2000.tb01017.x · doi:10.1111/j.2042-7174.2000.tb01017.x

Cited by

See all 175

Metadata

Authors
Jones, M. I., Greenfield, S. M., & Bradley, C. P.
Venue
BMJ
Publisher
BMJ
Published
2001-08-18
Volume
323
Issue
7309
Pages
378.1
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W1991598189
Cited by
175
References
1
FWCI
7.18
Type
journal article
Language
en
Open access
bronze
Licence
www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prescribing new drugs: qualitative study of influences on consultants and general practitioners. https://app.cochat.ai/papers/10.1136/bmj.323.7309.378
The paper
Jones, M. I., Greenfield, S. M., & Bradley, C. P. (2001). Prescribing new drugs: qualitative study of influences on consultants and general practitioners. BMJ. https://doi.org/10.1136/bmj.323.7309.378

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.